A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants
Clinical trial NCT05458076 · UNKNOWN
Trial details
- NCT number
- NCT05458076
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-03
- Primary completion
- 2022-09-06
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.